New combo therapy shows promise for restoring lost skin pigment

This study tested whether adding the drug apremilast to standard UVB light therapy helps restore skin color in people with vitiligo, a condition that causes white patches. Eighty adults with moderate to severe vitiligo received UVB light twice a week for 24 weeks, plus either apremilast or a placebo. The goal was to see if the combination leads to more repigmentation. While the treatment aims to control the disease and improve appearance, it is not a cure, and ongoing management may be needed.